New Medications and Emerging Therapies are Improving Quality of Life for Individuals with Chronic Migraines, says Cleveland Clinic Expert

Development of migraine-specific drugs to prevent and relieve the debilitating condition are proving highly effective, says a headache specialist

September 7, 2023, CLEVELAND: Medications developed over the past few years to treat migraines are significantly improving the quality of life for those with the debilitating condition, according to an expert from global health system Cleveland Clinic.

“Before 2018, when the FDA-approved the first calcitonin gene-related peptide (CGRP) inhibitor to prevent migraines, we had to rely on medications originally designed to treat other diseases, says Emad Estemalik MD, MBA, Section Head for Headache and Facial Pain at Cleveland Clinic’s Neurological Institute. “Today, however, there are several CGRP inhibitors available that have been developed to prevent or to relieve the symptoms of migraines specifically.”